Deutsche Bank
MRVI icon

Deutsche Bank’s Maravai LifeSciences MRVI Stock Holding History

Deutsche Bank’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9M Buy
4,304,927
+3,446,672
+402% +$14.9M 0.01% 786
2026
Q1 		$2.43M Buy
858,255
+10,724
+1% +$36.4K ﹤0.01% 1676
2025
Q4 		$2.75M Sell
847,531
-1,040,515
-55% -$3.5M ﹤0.01% 1617
2025
Q3 		$5.42M Buy
1,888,046
+13,703
+0.7% +$35K ﹤0.01% 1279
2025
Q2 		$4.52M Sell
1,874,343
-197,896
-10% -$416K ﹤0.01% 1285
2025
Q1 		$4.58M Buy
2,072,239
+835,600
+68% +$3.3M ﹤0.01% 1287
2024
Q4 		$6.74M Sell
1,236,639
-629,496
-34% -$4.05M ﹤0.01% 1183
2024
Q3 		$15.5M Buy
1,866,135
+239,318
+15% +$2.07M 0.01% 900
2024
Q2 		$11.6M Buy
1,626,817
+212,285
+15% +$1.83M 0.01% 963
2024
Q1 		$12.3M Hold
1,414,532
– – 0.01% 966
2023
Q4 		$9.27M Buy
1,414,532
+1,390,023
+5,671% +$8.98M ﹤0.01% 1033
2023
Q3 		$245K Sell
24,509
-1,434,756
-98% -$15.8M ﹤0.01% 2643
2023
Q2 		$18.1M Buy
1,459,265
+1,176,915
+417% +$15.9M 0.01% 813
2023
Q1 		$3.96M Buy
282,350
+206,528
+272% +$2.97M ﹤0.01% 1336
2022
Q4 		$1.09M Buy
75,822
+69,758
+1,150% +$1.1M ﹤0.01% 2008
2022
Q3 		$155K Buy
6,064
+227
+4% +$5.7K ﹤0.01% 3090
2022
Q2 		$166K Buy
5,837
+1,227
+27% +$38.9K ﹤0.01% 3268
2022
Q1 		$163K Sell
4,610
-19,254
-81% -$645K ﹤0.01% 3368
2021
Q4 		$1M Sell
23,864
-738,893
-97% -$29.9M ﹤0.01% 2437
2021
Q3 		$37.4M Buy
762,757
+689,015
+934% +$33.6M 0.02% 698
2021
Q2 		$3.08M Sell
73,742
-22,116
-23% -$857K ﹤0.01% 1860
2021
Q1 		$3.42M Buy
95,858
+41,909
+78% +$1.39M ﹤0.01% 1800
2020
Q4 		$1.51M Buy
+53,949
New +$1.5M ﹤0.01% 2127

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's MRVI Position: Q2 2026 in Review

Deutsche Bank increased its Maravai LifeSciences (MRVI) stake by 402% in Q2 2026, buying an estimated $14.9M and bringing the position to 4,304,927 shares worth $26.9M. The position accounts for 0.01% of the portfolio, ranked #786.

Deutsche Bank first reported a position in MRVI in Q4 2020 and has held it in 23 quarters since. The position peaked at $37.4M in Q3 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Deutsche Bank held 4,304,927 shares of Maravai LifeSciences worth $26.9M as of Q2 2026.
  • Deutsche Bank bought 3,446,672 Maravai LifeSciences shares in Q2 2026, an estimated $14.9M.
  • Maravai LifeSciences made up 0.01% of Deutsche Bank's portfolio in Q2 2026, its #786 holding.
  • Deutsche Bank first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 23 quarters since.
  • Deutsche Bank's Maravai LifeSciences position peaked at $37.4M in Q3 2021.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.